Hodgkin lymphoma survivors face twice the risk of death compared to average American adult
A study from the MD Anderson Cancer Center reveals that five-year Hodgkin lymphoma survivors face double the mortality risk of the general population. While cancer recurrence is a factor, the research emphasizes that cardiovascular disease and secondary cancers are major contributors to long-term mortality.
Why it matters
This research underscores the critical need for specialized, long-term survivorship care for cancer patients to address chronic health risks beyond the initial treatment phase.
by University of Texas MD Anderson Cancer Center
edited by Lisa Lock , reviewed by Andrew Zinin
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Add as preferred source Line graph of cumulative mortality among 5-year Hodgkin lymphoma survivors from 16 surveillance, epidemiology, and end results registries, 2000–2017. Credit: JAMA Network Open (2026). DOI: 10.1001/jamanetworkopen.2026.29775 Adults who have survived Hodgkin lymphoma (HL) for at least five years face significantly elevated long-term health risks, according to a new study led by researchers at The University of Texas MD Anderson Cancer Center.
The retrospective, population-based study, published today in JAMA Network Open , was led by Bryan Valcarcel, M.D., instructor, and Luis Malpica Castillo, M.D., associate professor, both of Lymphoma & Myeloma.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in